Triple GH Optimization Blend Triple combination for comprehensive GH optimization
Your weight loss journey starts with an initial consultation with Alexa, where she will assess your individual needs, health history, and weight loss goals
Genetic variants acting as proxies for GLP-1RAs show the lifelong effects of changes in HbA1c levels and GLP-1R gene expression on SA risk, and this impact may not be comparable to the short-term effects of glucose-lowering drugs
This routine monitoring ensures that your body maintains healthy B12 levels as you continue your weight loss journey

Primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, meaning insulin secretion increases when blood glucose is elevated but not when glucose levels are normal or low, reducing hypoglycemia risk Suppressed glucagon secretion : These medications inhibit glucagon release from pancreatic alpha cells, decreasing hepatic glucose production Delayed gastric emptying : GLP-1 receptor activation slows the rate at which food leaves the stomach, moderating postprandial glucose excursions Central appetite regulation : GLP-1 receptors in the brain, particularly in areas controlling satiety and food reward, are activated, leading to reduced appetite and caloric intake These combined effects result in improved glycemic control in patients with type 2 diabetes and significant weight loss in both diabetic and non-diabetic individuals

Retatrutide is what scientists call a "triple agonist" because it activates three hormone receptors simultaneously: GLP-1, GIP, and glucagon